Fifteen adult patients, admitted to Baragwanath Hospital ICU with septic shock after adequateJluid loading and on no other inotropic agents, were given adrenaline in incremental doses. Oxygen transport and haemodynamic variables were monitored with each dose increment until a systolic blood pressure of 120 mmHg was obtained. This was reached on an average dose of adrenaline ofO.16±0.02 j1glkglmin. Mean arterial blood pressure increased by 22±2 mmHg mainly due to an increase in cardiac index (J±0.2 IIminlm2) and systemic vascular resistance index (J 30±41 dyn.s.cm.-5 m-2j with a small increase in heart rate of 8±3 beats per minute. Oxygen delivery was increased with no significant increase in oxygen consumption and lactate levels increased. Adrenaline is therefore an effective initial inotropic agent. Patients may respond to lower doses than when used concurrently with other inotropic agents but there was still a significant dose variation in response. We cannot, however, exclude a deleterious effect on oxygen utilization.
Textbooks state that inotropic agents have markedly different effects on various vascular beds. I , 2 The majority of this work has, however, been done on either animal models or human volunteers and not in patients with sepsis or septic shock. The human studies that have investigated septic shock have principally concentrated on the use of inotropic agents such as dobutamine,3,4 dopamine 5 and noradrenaline 6 ,7 and very little work has been done on documenting the haemodynamic effects of adrenaline in septic shock. Adrenaline is widely used in South Africa, the U.K. and Australia, and therefore the aim ofthe study was to document the effects of adrenaline on haemodynamics and oxygen transport when used as a first-line inotropic agent in patients with septic shock.
The primary haemodynamic derangements in septic shock consist of myocardial depression,8,9 peripheral vascular failure 10 and possible alterations in adrenergic receptor activity.II-16 These derangements vary from patient to patient and during each septic insult, and therefore it is not surprising that the dose of catecholamines varies during the actual insult and from patient to patient. Adrenaline has been successfully used as a secondline inotropic agent after dopamine '7 or dobutamine. 18 These other agents may result in downregulation of adrenoreceptors,19.22 and we therefore thought that when adrenaline was used as an initial agent, patients might respond differently, Adrenaline is potentially both an inotropic and a vasoconstrictor agent and therefore may be a very useful means of treating septic shock. METHODS All adult patients admitted to our unit from August 1990 until September 1991 with septic shock who needed inotropic support but were on no other inotropic agents besides low-dose dopamine at 2-311g/kg/min, and who had a pulmonary artery catheter in situ, were entered into the trial. We defined septic shock as a systolic blood pressure of 90 mmHg or less, or a drop of 50 mmHg from baseline in patients who had been adequately fluid resuscitated with a pulmonary capillary wedge pressure (PCWP) of at least 12 mmHg.23 In addition all patients had an obvious septic focus or a documented bacteraemia on blood culture and had hyperdynamic circulation which was assessed clinically. Our patients all had decreased organ perfusion as evidenced by a urine output of less than 20 mllhr, lactic acidosis (> 2.5 mmoVI) or mental confusion.
Ethics committee approval was obtained prior to commencement of the study and, where possible, informed consent was obtained. Basic demographic data including height and weight were recorded on entry to the trial.
Our protocol for the treatment of septic shock has been described previously.24 All patients were mechanically ventilated if indicated to maintain high arterial oxygen contents with a P a 0 2 > 60 mmHg and a saturation of > 95%. This frequently required high inspired O 2 concentrations. A radial arterial line was inserted if not already present and all patients had a pulmonary artery catheter in situ. ECG rhythm was monitored continuously. This enabled measurement of heart rate, systolic and diastolic blood pressure, right atrial pressure and end-expiratory PCWP and pulmonary arterial pressures. Thermodilution cardiac output was recorded as the mean of three readings within 10% of each other after injection of 10 ml of 5% dextrose water at less than 4·C and computed by a Nikon Koden® lifescope monitor. Using these variables cardiac index (Cl), systemic vascular resistance (SVR), right ventricular stroke work index (RVSWI) and left ventricular stroke work index (L VSWI) were calculated. Mixed venous and arterial oxygen saturation, haemoglobin concentration and partial pressure of oxygen (P a 0 2 ) were measured using standard laborat?ry methods. Oxygen delivery (002) and consumptlon (V0 2 ) and the oxygen extraction ratio (02ER) were calculated using standard formulae. The above measurements were done prior to the adrenaline infusion and with each dose increment. We measured lactate levels prior to commencement of the study and one hour after the end-point had been reached.
After the initial baseline measurements had been taken, the adrenaline infusion was started using a continuous infusion pump at a dose ofO.025llglkgl min. This was increased by 0.025 Ilglkglmin every 20 minutes, until a sustained increase of systolic blood pressure to above 120 mmHg, an increase in SVR of 200 dyn.s.cm-5 above baseline or an increase in heart rate of above 20% of that initially recorded, was obtained. The PCWP was kept constant throughout the study and if necessary patients were given small fluid boluses. Patients were withdrawn if any significant clinical deterioration occurred or if any life-threatening arrhythmias were noted.
All values are expressed as mean ± SE with 95% confidence intervals. The paired Student's t test was utilized to assess variance with a Pvalue ofless Anaesthesia and Intensive Care, Vol. 20, No. 4, November, 1992 than 0.05 being considered as statistically significant. Confidence intervals of 95% were calculated to determine clinical significance of differences.
RESULTS
The demographic and clinical details of the patients are shown in Table I . The overall ICU mortality rate was 66% with an average admission Apache 11 score of 20.
Hypotension was successfully reversed in all patients on doses of adrenaline ranging from 0.05 to 0.3 Ilglkglmin. This increase in blood pressure was partially due to an increase in cardiac index (23%) and SVR (16%), ( Table 2) , both of which reached statistical significance. The L VSWI increased markedly by 70%. Although the increase in SVR did reach statistical significance, the response was unpredictable and varied from patient to patient. A small, statistically significant increase in heart rate did occur, but an increase of 8 (2;14 95% Cl) beats per minute was pr?b~bly of little clinical significance. There was no SIgnIficant change in pulmonary artery pressures and pulmonary vascular resistance and the PCWP was kept constant as per design.
. The oxygen delivery was m~rkedly increased with no consistent increase in V0 2 , although the nonsurvivors showed a decrease in v0 2 with increased Do2 and therefore reduced 02ER. Lactate levels were measured in 13 of the patients and increased by 1.3 mmol/l (0.2;2.4 95% Cl). Of the five patients who survived, four showed no change or small decreases in lactate levels, whereas in the eight patients who -died and had lactate measured, all showed an increase in lactate levels.
No arrhythmias or any significant ECG changes indicating myocardial ischaemia were noted. One patient had to be excluded due to significant worsening of the underlying condition with no response to adrenaline. In most patients urine output increased although this was not consistent and did not reach statistical significance.
DISCUSSION
This study has confirmed the beneficial haemodynamic effects of adrenaline in human septic shock subsequent to fluid resuscitation.
The overall ICU mortality rate of66% correlates with that previously described for this condition. 25 Our patients were predominantly young with severe physiological derangements on admission to ICU, as is shown by an average admission Apache 11 score of 20.
Adrenaline has both endogenous u-and J3adrenergic effects. It has been thought that at doses No  Age   I   30  2  24  3  35  4  35  5  30  6  50  7  55  8  38  9  58  \0  25  11  51  12  68  13  37  14  34  15 24 In our previous studyl8 of patients treated with adrenaline for septic shock who were on constant doses of dobutamine, we did not show any vasodilatory effects at low doses. This could have been due to the decreased vascular responsiveness of septic shock or due to the ~stimulatory effects of dobutamine.
In that study we did show a consistent increase in SVR at varying doses with no change in cardiac output. This suggests that adrenaline has both ~ and a-effects, as pure Ill-stimulation would only increase cardiac output whereas pure a-stimulation would cause an increased SVR with a subsequent drop in cardiac output. In our present study using adrenaline as an initial inotropic agent, we again could show no vasodilatory effect of adrenaline in sepsis and rather an increase in SVR but this time with an increased cardiac output. This suggests that adrenaline must have some Ill-action in septic shock. Possible reasons for the increased cardiac output in the present study compared with that in the previous one could be the 'maximal' Ill-effect Part of the vasopressor effect we have demonstrated was due to the increase in SVR, probably as a result of a-stimulatory effects. The increase in heart rate was minimal and was probably oflittle clinical significance. The striking haemodynamic effect, however, was a consistent increase in blood pressure with marked increases in cardiac output and L VSWI.
Previous studies using adrenaline have primarily concentrated on its use in other situations and not in septic shock. Coffin 27 showed that hypotension and oliguria could be reversed in healthy volunteers and Steen 28 showed that low dose of adrenaline (0.04 ~g!kg!min) caused increased cardiac output and blood pressure with no effect on SVR in post cardiac surgical patients.
Bollaert et at. 17 showed in 13 patients that adrenaline reversed hypotension in patients with resistant septic shock. This was due to an increase in cardiac output and SVR. All of the patients were on high doses of dopamine prior to the use of adrenaline and required very high doses of adrenaline ranging from 0.5 to 1 ~g!kg!min. In our previous studyl8 we showed that doses of adrenaline ranging from 0.11 to 0.4 7 ~g!kg!min could be used as an effective vasoconstrictor in septic shock once on constant doses of dobutamine prior to the use of adrenaline.
The above two studies l7 ,18 have shown that adrenaline is effective in septic shock, but in both adrenaline was used after another drug had been instituted and much later on in the septic insult. In our present study we showed adrenaline to have similar haemodynamic effects but at lower doses. Although this seems to be the case, it may be due to the fact that the patient groups in the various studies were not comparable, or that there was a considerable variation in adrenaline requirements between patients. Nevertheless the high doses required in other studies may be due to the progressive attenuation of vascular responsiveness which has been shown in animal models to occur in the presence of endotoxin"· 16 or the myocardial depression which occurs in sepsis. 8 ,9 All the inotropic agents probably result in a down regulation of l3-adrenergic receptors 1 9-2 1 and this may be a further explanation for the lower doses needed when used as a first-line agent.
Recently Mackenzie et al. 29 showed very similar results to ours in 13 patients with septic shock. Their patients were of an older age group and not all of them had a hyperdynamic circulation. They used doses ranging from 0.05 to 0.42 ~g!kg!min and also showed no consistent change in SVR. A marked increase in Do 2 was shown with minimal increases in V0 2 and therefore marked reductions in 02ER. Lactate levels were not measured.
The increase in D0 2 is desirable but the lack of increase in v0 2 might be cause for concern. v0 2 has been shown previously to be supply-dependent in septic shock and improved outcome has been associated with increased oxygen delivery.30,31 Not all of our patients had significantly increased levels of lactate prior to commencement of the study and therefore might not all have had a significant oxygen debt. This may partially explain the lack of increase in v0 2 . In the three patients however, with lactate levels above 2.5 mmolll, there was a minimal increase in oxygen consumption with increased delivery. We can however still not exclude the fact that adrenaline may have a negative effect on oxygen utilization with a wasted increase in delivery, and further work will have to be done to elucidate this. It is possible that adrenaline adversely affects perfusion of essential vascular beds, thus preventing regional oxygen delivery, and therefore there would be no overall increase in oxygen consumption.
The overall increase in lactate was difficult to interpret although again an increase in metabolic demand in underperfused tissues cannot be excluded. It has been suggested that the transient increase in lactate may be due to washout 32 and as we only measured lactate levels at one hour after infusion we are unable to document whether this was a persistent effect. Adrenaline itself has been shown in healthy volunteers to stimulate glycogenolysis directly. 33 In this study we have therefore shown that adrenaline is an effective initial inotropic agent in patients with septic shock when given early on in the septic insult. Our patients seemed to respond to a lower dose than that required when other inotropic agents were used concurrently. This could be due to altered vascular responsiveness due to endotoxin l 4-16,22 or due to down regulation of 13receptors from the concomitant use of other ~ agonists. ' 9-21 It may, however, simply due to the fact that the patients in our study were not matched with the groups in previous studies, or that it was simply due to the varied response that is seen with adrenaline. A variable dose response was shown between patients and therefore we recommend that if adrenaline be used in septic shock, patients be closely haemodynamically monitored. A deleterious effect on oxygen utilization cannot be excluded and a study monitoring serial oxygen consumption variables, including lactate, in patients on adrenaline needs to be carried out to address this problem. We also only assessed the short-term effects of adrenaline, and the long-term effects still need to be investigated.
